342 related articles for article (PubMed ID: 15193142)
1. PTEN function: how normal cells control it and tumour cells lose it.
Leslie NR; Downes CP
Biochem J; 2004 Aug; 382(Pt 1):1-11. PubMed ID: 15193142
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase.
Leslie NR; Gray A; Pass I; Orchiston EA; Downes CP
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):827-33. PubMed ID: 10698713
[TBL] [Abstract][Full Text] [Related]
3. The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover.
Maehama T; Okahara F; Kanaho Y
Biochem Soc Trans; 2004 Apr; 32(Pt 2):343-7. PubMed ID: 15046605
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel effectors of invasive cell growth downstream of phosphoinositide 3-kinase.
Kaufmann J; Pronk G; Giese K; Klippel A
Biochem Soc Trans; 2004 Apr; 32(Pt 2):355-9. PubMed ID: 15046608
[TBL] [Abstract][Full Text] [Related]
5. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.
Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP
Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368
[TBL] [Abstract][Full Text] [Related]
6. New insights into PTEN.
Tamguney T; Stokoe D
J Cell Sci; 2007 Dec; 120(Pt 23):4071-9. PubMed ID: 18032782
[TBL] [Abstract][Full Text] [Related]
7. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
Steelman LS; Bertrand FE; McCubrey JA
Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
[TBL] [Abstract][Full Text] [Related]
8. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
[TBL] [Abstract][Full Text] [Related]
9. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells.
Lin HK; Hu YC; Lee DK; Chang C
Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473
[TBL] [Abstract][Full Text] [Related]
10. The role of PTEN in the progression and survival of prostate cancer.
Deocampo ND; Huang H; Tindall DJ
Minerva Endocrinol; 2003 Jun; 28(2):145-53. PubMed ID: 12717346
[TBL] [Abstract][Full Text] [Related]
11. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
12. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
13. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.
Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K
Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163
[TBL] [Abstract][Full Text] [Related]
14. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
[TBL] [Abstract][Full Text] [Related]
15. Phosphatase and tensin homologue growth suppression without phosphatase.
Stokoe D; Costello JF
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2677-8. PubMed ID: 15710873
[No Abstract] [Full Text] [Related]
16. The biology and clinical relevance of the PTEN tumor suppressor pathway.
Sansal I; Sellers WR
J Clin Oncol; 2004 Jul; 22(14):2954-63. PubMed ID: 15254063
[TBL] [Abstract][Full Text] [Related]
17. PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T; Taylor GS; Dixon JE
Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
[TBL] [Abstract][Full Text] [Related]
18. Enhanced protein kinase B/Akt signalling in pituitary tumours.
Musat M; Korbonits M; Kola B; Borboli N; Hanson MR; Nanzer AM; Grigson J; Jordan S; Morris DG; Gueorguiev M; Coculescu M; Basu S; Grossman AB
Endocr Relat Cancer; 2005 Jun; 12(2):423-33. PubMed ID: 15947113
[TBL] [Abstract][Full Text] [Related]
19. Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate.
Campbell RB; Liu F; Ross AH
J Biol Chem; 2003 Sep; 278(36):33617-20. PubMed ID: 12857747
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neuronal phenotype by PTEN in PC12 cells.
Musatov S; Roberts J; Brooks AI; Pena J; Betchen S; Pfaff DW; Kaplitt MG
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3627-31. PubMed ID: 14990793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
